NCT05286970View on ClinicalTrials.gov

A Clinical Study of AK115 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

September 28, 2022

Study Completion Date

September 28, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

AK115

Abdominal subcutaneous injection

DRUG

Placebo

Abdominal subcutaneous injection

Trial Locations (1)

650000

Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming

Sponsors

Lead Sponsor

Akeso
All Listed Sponsors
lead

Akeso

INDUSTRY

NCT05286970 - A Clinical Study of AK115 in Healthy Subjects | Biotech Hunter | Biotech Hunter